It was a great pleasure to meet with Dr Christina Muzny (University of Alabama at Birmingham, Birmingham, AL, USA) to discuss the hot topics and latest research in bacterial vaginosis and trichomoniasis treatment and prevention.
- What are the hot topics and latest research you are looking forward to exploring in the bacterial vaginosis and trichomoniasis treatment and prevention field during 2021? (0:18)
Disclosures: Christina Muzny has received research grants to my UAB from, NIH, Lupin, Gilead, Abbott; is on the Speaker Board for Cepheid; is on Scientific Advisory Boards for PhagoMed, Roche, Abbott; receives speaker honoraria from Cepheid, Roche, BD, Abbott; and is involved in the development of educational presentations for Jesperson & Associates.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Share this Video
Related Videos In Bacterial and Fungal Infections
Jinhee Jo, IDWeek 2021: Global Surveillance of Clostridioides difficile
It was a pleasure to meet with Dr Jinhee Jo (Department of Pharmacy Practice and Translational Research, University of Houston, Houston, TX, USA) to discuss her study investigating the understanding of how C. Difficile is transmitted, and who it affects. The abstract entitled: ‘Global Surveillance of Clostridioides difficile Demonstrates High Prevalence in Non-Healthcare Settings’ was […]
Kevin Garey, IDWeek 2021: Health-related Quality of Life Findings from the ECOSPOR Phase 3 Trial
It was a pleasure to meet with Prof. Kevin Garey (University of Houston College of Pharmacy, Houston, TX, USA) to discuss the results from the ECOSPOR phase 3 trial, and how SER-109 impacts patients’ health-related quality of life. Watch Part 1 of this interview here. The abstract entitled: ‘The Impact of Investigational Purified Microbiome Therapeutic […]
Kevin Garey, IDWeek 2021: Limitations of Current Treatment Approaches for Recurrent C difficile Infections
We had the great pleasure of meeting with Prof. Kevin Garey (University of Houston College of Pharmacy, Houston, TX, USA) to discuss the health burden of C difficile infections, and the limitations of current treatment approaches. Watch Part 2 of the interview here. The abstract entitled: ‘The Impact of Investigational Purified Microbiome Therapeutic SER-109 on […]
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!